KALA BIO, Inc. - KALA Profit before interest, taxes and amortization

Graphic logo of kalarx.com (KALA)

KALA BIO, Inc. (KALA) maintains stable sales based on the patent protection of its unique anti-inflammatory drops. The company's EBITDA reflects cash flow dynamics, where 0.00 determines the current value of the metric. Demand for such drugs remains independent of economic cycles, while the upcoming results of stem cell therapy clinical trials serve as a key growth driver.

kalarx.com (KALA) Profit before payment of interest, taxes and amortization: for the period 11/23/2025 - 11/14/2026

KALA BIO (KALA) - metric breakdowns and financial figures

- market value and analyst target forecast:
Market Price KALA BIO Inc.|KALA - Consensus Target
- issuer market value details:
Market Value KALA BIO|KALA - Enterprise Value
- book capitalization data:
Net Asset Value per Share KALA BIO|KALA - Company Book Value|Market Capitalization to Book Value kalarx.com|KALA - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Capital KALA BIO, Inc.|KALA - Long-Term Debt to Capital|Short-Term Debt to Capital KALA BIO Inc.|KALA - Company Debts|Debt to Book Capitalization Ratio KALA BIO|KALA - Company Long-Term Debts|Company Short-Term Debts KALA BIO|Intermediate Coverage Ratio kalarx.com
- earnings and market multiples details:
KALA - Net Profit|Expected Profit KALA BIO, Inc.|KALA - P/E Multiple|Market Cap to Projected Earnings KALA BIO Inc.|KALA - Price/Earnings to Growth Ratio|Company Value to EBITDA KALA BIO|KALA - Operating profit before deduction of amortization|Earnings per share for the trailing year KALA BIO|KALA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months kalarx.com|KALA - Earnings per share growth in current year|Projected earnings per share growth rate for next year KALA BIO, Inc.
- sales and revenue data:
KALA - Revenue and Sales Volume|Company Future Sales Volume KALA BIO Inc.|KALA - Market Cap to Revenue|Market Cap to Expected Sales Ratio KALA BIO
Analysis of all company metrics:KALA BIO, Inc. (KALA)
Original product of KALA BIO

This metric captures the actual cash flow from core operations, adjusted for depreciation and financial expenses, allowing for a real-time assessment of business liquidity. For KALA BIO, Inc. (KALA), which currently lacks sales, monitoring EBITDA_Co reflects the capital burn rate on R&D until patent protection is realized and premium pricing power is established for its ophthalmic drugs.

Who KALA BIO, Inc. competes with

Alcon Corp (ALC) - Profit before interest, taxes and amortization|BLCO: Operating profit before deduction of amortization|Profit before interest, taxes and amortization glaukos.com|APLS: Operating profit EBITDA|Profit before interest, taxes and amortization Belite Bio Pharma (BLTE)|Profit before payment of interest, taxes and amortization Ocular Therapeutix Corp|Harrow Corp (HROW) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Viridian Therapeutics (VRDN)|Operating profit EBITDA lenz-tx.com (LENZ)|Operating profit EBITDA OCS (Oculis Holding)|Operating profit EBITDA EyePoint Pharmaceuticals Inc EYPT|KOD - Profit before payment of interest, taxes and amortization|ALDX: Profit before payment of interest, taxes and amortization|IRD: Operating profit EBITDA|OKYO Pharma (OKYO) - Operating profit EBITDA|Operating profit before deduction of amortization ADVM|OTLK: Income before deduction of interest, taxes and amortization|Operating profit EBITDA CLSD|Profit before payment of interest, taxes and amortization NBY (novabay.com)|Operating profit EBITDA KPRX (Kiora Pharmaceuticals, Inc.)|Operating income before deduction of amortization Alimera Sciences Inc (ALIM)|EYEN - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Guardion Health Sciences, Inc.|OCUP (Ocuphire) - Operating profit before deduction of amortization|Opthea Corp - Income before deduction of interest, taxes and amortization